Micron Solutions Inc Receivables Turnover Ratio (MICR), from the fourth quarter 2019 to the fourth quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Micron Solutions Inc  (NYSE: MICR)
 

Micron Solutions Inc Accounts Receivables Turnover Ratio from the fourth quarter 2019 to the fourth quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Micron Solutions Inc's ability to collect accounts receivable sequentially worsen to 7.3, indicating more challenging environment then in the third quarter 2019, but still, it is a far cry from any concerns. Micron Solutions Inc's Accounts Receivable average collection period in the Dec 31 2019 quarter, has increased to 50 days, from 49 days, in the Sep 30 2019 quarter.

If we take a look into Healthcare sector 212 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2019 from 2044 to 2052.

What is Receivable Turnover Ratio?
What is Micron Solutions Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MICR Receivables Turnover Ratio (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Receivable Change -7.46 % -18.78 % -25.16 % -10.49 % -10.38 %
Y / Y Revenue Change -12.94 % -13.4 % -8.05 % -8.47 % -9.14 %
Receivable Turnover Ratio (TTM) 7.3 7.39 7.26 6.91 6.87
MICR's Total Ranking # 2052 # 2044 # 2042 # 420 # 1622
Accounts Receivable average collection period days 50 49 50 53 53
Seq. Receivable Change -9.55 % 4.15 % -17.44 % 18.98 % -20.61 %
Seq. Revenue Change -17.11 % -11.47 % 4.41 % 13.62 % -17.55 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 60
Healthcare Sector # 213
Overall Market # 2052

Receivable Turnover Ratio Statistics
High Average Low
7.39 6.09 3.5
(Sep 30 2019)   (Mar 31 2018)





MICR Company Profile • Back to MICR Efficiency Comparisons • Compare MICR Receivables Turnover Ratio to its Competitors

Financial Statements
Micron Solutions Inc's Accounts Receivable $ 2 Millions Visit MICR's Balance sheet
Micron Solutions Inc's Sales TTM $ 17 Millions Visit MICR's Income Statement
Sources of MICR's Revenues Visit MICR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MICR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MICR's Growth Rates MICR's Roa MICR's Inventory Turnover Ratio MICR's Dividend Comparisons
MICR's Profitability Ratios MICR's Roi MICR's Asset Turnover Ratio MICR's Dividend Growth
MICR's Valuation Ratios MICR's Roe MICR's Financial Strength Ratios MICR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2019 Receivable at quarter ending Dec 31 2019
Ernexa Therapeutics Inc   22.25 $ 19.806  Millions$ 0.890  Millions
Harrow Inc   22.15 $ 51.165  Millions$ 2.310  Millions
Tearlab Corp  22.02 $ 22.655  Millions$ 1.029  Millions
Mimedx Group Inc   21.54 $ 299.255  Millions$ 13.894  Millions
Emmaus Life Sciences Inc   20.74 $ 22.752  Millions$ 1.097  Millions
Parallax Health Sciences Inc   20.43 $ 0.129  Millions$ 0.006  Millions
Aveo Pharmaceuticals Inc   19.51 $ 28.795  Millions$ 1.476  Millions
Acadia Healthcare Company Inc   18.71 $ 6,402.018  Millions$ 342.085  Millions
Ibio inc   18.07 $ 1.744  Millions$ 0.097  Millions
Immunogen inc   17.99 $ 82.271  Millions$ 4.573  Millions
China Biologic Products Holdings Inc   17.68 $ 503.745  Millions$ 28.494  Millions
Dariohealth Corp   17.57 $ 7.559  Millions$ 0.430  Millions
Kyntra Bio Inc   17.06 $ 256.577  Millions$ 15.039  Millions
Invo Fertility Inc   16.94 $ 1.480  Millions$ 0.087  Millions
Bellicum Pharmaceuticals Inc   16.06 $ 8.494  Millions$ 0.529  Millions
Imac Holdings Inc   15.91 $ 15.126  Millions$ 0.951  Millions
Reflect Scientific Inc  15.64 $ 1.609  Millions$ 0.103  Millions
Vbi Vaccines Inc  15.64 $ 2.221  Millions$ 0.142  Millions
Uniqure N v   15.62 $ 7.281  Millions$ 0.466  Millions
Mannkind Corporation  15.43 $ 63.038  Millions$ 4.085  Millions
Cv Sciences Inc   15.15 $ 53.696  Millions$ 3.545  Millions
Chemed Corporation  15.09 $ 1,938.555  Millions$ 128.499  Millions
Corcept Therapeutics Inc  15.07 $ 306.486  Millions$ 20.331  Millions
Otonomy Inc   14.72 $ 0.600  Millions$ 0.041  Millions
Neurometrix Inc   14.71 $ 9.273  Millions$ 0.630  Millions
Neuropathix Inc.  14.62 $ 0.262  Millions$ 0.018  Millions
Cti Biopharma Corp   14.08 $ 4.625  Millions$ 0.329  Millions
Cogent Biosciences Inc   14.04 $ 22.499  Millions$ 1.603  Millions
Musclepharm Corporation  14.02 $ 79.667  Millions$ 5.681  Millions
Sanuwave Health Inc   13.61 $ 1.529  Millions$ 0.112  Millions

Date modified: 2026-06-22T14:32:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.